Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients.
about
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalisThrombocytopenia in critically ill surgical patients: a case-control study evaluating attributable mortality and transfusion requirementsClinical review: fever in intensive care unit patientsClinical manifestations, laboratory findings, and treatment outcomes of SARS patients.Deficiency of ADAMTS-13 in pediatric patients with severe sepsis and impact on in-hospital mortalityBundled care for septic shock: an analysis of clinical trials.Multiplex PCR to diagnose bloodstream infections in patients admitted from the emergency department with sepsis.Existing data sources for clinical epidemiology: The North Denmark Bacteremia Research Database.Approach to a patient with urosepsis.Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency MedicineInfluence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms.Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care?New developments in the treatment of gram-negative bacteremia.Epidemiology and outcome of nosocomial and community-onset bloodstream infection.Endotoxemia: methods of detection and clinical correlatesFulminant gangrene in transient cold agglutinemia associated with Escherichia coli infection.The role of the infectious diseases physician in setting guidelines for antimicrobial useSynergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis.Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosa.Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome.Antipyretic therapy in critically ill patients with sepsis: an interaction with body temperature.Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients.Double-blind, prospective, multicenter trial comparing ceftazidime with moxalactam in the treatment of serious gram-negative infectionsRecombinant alpha 1-antitrypsin Pittsburgh attenuates experimental gram-negative septicemiaThe effect of sepsis upon gentamicin pharmacokinetics in neonates.Combination therapy for treatment of infections with gram-negative bacteria.Early antipyretic exposure does not increase mortality in patients with gram-negative severe sepsis: a retrospective cohort study.Timing of specimen collection for blood cultures from febrile patients with bacteremia.Short-term heat exposure inhibits inflammation by abrogating recruitment of and nuclear factor-{kappa}B activation in neutrophils exposed to chemotactic cytokinesCritical care in the emergency department: severe sepsis and septic shockGram-negative sepsis: a dilemma of modern medicineThe gastrointestinal immune system: Implications for the surgical patient.Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection model.Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxinDirect susceptibility testing of positive blood cultures by using Sensititre broth microdilution plates.Effect of protein malnutrition on salmonellosis and fever.Dissociation of systemic and renal effects in endotoxemia. Prostaglandin inhibition uncovers an important role of renal nerves.Evaluation of the Cobas-Bact system for direct and rapid identification and antimicrobial susceptibility testing of gram-negative rods from positive blood culture brothsCounterpoint: Should antipyretic therapy be given routinely to febrile patients in septic shock? No.
P2860
Q24644984-B2D52D22-61EC-442C-89AD-17D1156B2D8EQ24645094-7A9A56E0-2673-4BC9-8829-B8D7716EFA12Q24794504-9E643977-F5B7-4D43-ADB9-4291BD6CFEF9Q24794689-3FA70C51-C8E6-496F-A261-7EA3602A4FD7Q33361306-7EBF6A38-C809-452F-895B-478A1612239EQ33406706-E5BEA186-4D1D-4F13-9314-E7D99ECD147FQ33520432-1C54B60E-D18D-4545-8BED-7F74E4526848Q33614220-6F9F7453-57E4-4F40-8954-93F9A5CF7563Q33701678-F30AA2D6-76CD-4798-8063-08DDE3FFAEBFQ33736385-659D5E65-39AE-40F9-8C1F-ECB52F029753Q33974292-4FC478E0-1E7E-4915-937F-E33D655F565EQ34108527-4FFA9770-5043-427D-AA1A-0A43E9DC7734Q34169255-D7463659-5A1B-4AC5-8703-BE22DF577958Q34193370-1C940B8A-C2DE-4323-83F2-3DBEDEC9088AQ34220412-669EC6A5-D090-44B7-87AE-C42515EC90FFQ34300796-529CC514-99AC-461C-ADF8-82DFAAECD243Q34301298-A9059156-08AE-445D-9065-11F98573AE6DQ35119823-4186B64D-33E2-4738-94F7-3AE8AD7A06EBQ35121455-95747C81-1BB1-4A7A-BC19-F90EBAEEAB1CQ35122113-7AFACFE2-9D1B-4965-AA82-F61BBEA65804Q35225933-E8A9728A-05B2-448F-B1E3-22D08037A92EQ35230730-9B4A32FF-554E-4D24-8435-F49E45AE8439Q35304730-79145EC5-1AFC-409F-9E1E-42F0E5E40FB1Q35574202-B44A2664-3C80-404A-BB34-2DCEB4C6A7D4Q35818183-62B6E82F-E303-4FF3-A939-A8BA8CEBE96FQ35827298-3A74F48A-86BA-42AB-84AB-12462AB89846Q36156077-7A68B575-2C76-4474-9D3F-E6F45EE8E567Q36435051-E0F22D3E-C1D0-4042-A85F-8D1CA0E68195Q36539899-C297B64D-8233-4E7C-9203-D5D3366C1466Q36559688-DBFB8A05-8A25-48BA-8EFF-E99CCDC19452Q36571939-832E8911-3420-4990-BD0F-D07AF723769FQ36639504-5502A9AD-4FB6-44F3-B0B0-FE83E8488011Q36738035-3D3FD5DB-B0E9-46A4-929E-57BE313B62CEQ36754206-E79023E7-D309-46E6-BF7B-354B44CE3FC9Q36806311-2DF53D0F-4139-45C6-B2B1-0EF8F33E0EDAQ36892048-5FC7BEB7-3A1E-4E2C-8E54-415CBBF71169Q36996363-41CC221B-EDF2-4820-B336-5C3121D31AA9Q37008833-F01475B8-831B-47CC-AC1E-DA163C974B3CQ37167437-23683DAC-B9E9-458D-ABC1-2F7E82964E32Q37209558-CEF89F7C-8BBC-4B05-A099-011451C1FF5E
P2860
Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients.
description
1980 nî lūn-bûn
@nan
1980 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի մարտին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Gram-negative bacteremia. IV. ...... and treatment in 612 patients.
@ast
Gram-negative bacteremia. IV. ...... and treatment in 612 patients.
@en
type
label
Gram-negative bacteremia. IV. ...... and treatment in 612 patients.
@ast
Gram-negative bacteremia. IV. ...... and treatment in 612 patients.
@en
prefLabel
Gram-negative bacteremia. IV. ...... and treatment in 612 patients.
@ast
Gram-negative bacteremia. IV. ...... and treatment in 612 patients.
@en
P2093
P1476
Gram-negative bacteremia. IV. ...... and treatment in 612 patients.
@en
P2093
P304
P356
10.1016/0002-9343(80)90102-3
P407
P577
1980-03-01T00:00:00Z